For example, MDM2 amplification is present in most dedifferentiated liposarcomas and typically co-amplified with CDK4 and/or HMGA2, synovial sarcomas (SS) are often characterized by SS18–SSX fusions, and presence of MYOD1 mutations indicate spindle cell/sclerosing rhabdomyosarcoma [2,3]. This evidence concerns the gene MYOD1 and synovial sarcoma.